CD276 and breast cancer: In physiological conditions, immune checkpoints (as the identified DEGs VTCN1 and CD276) are crucial to prevent exaggerated inflammation, which would otherwise cause damage to the tissues; however, through upregulation of immune checkpoints, BC cells can also acquire the ability to suppress the immune response and evade recognition and consequent elimination by the immune system [47].